Citadel Advisors
TCBP

Citadel Advisors’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

Citadel Advisors’s Portfolio TCBP Stock Details TCBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-141
Closed -$18.5K – 15699
2024
Q2 		$18.5K Buy
+141
New +$28.2K ﹤0.01% 12712
2023
Q4 		– Sell
-4
Closed -$5.65K – 15587
2023
Q3 		$5.65K Sell
4
-20
-83% -$33K ﹤0.01% 13376
2023
Q2 		$40K Buy
+24
New +$77.1K ﹤0.01% 12064
2022
Q2 		– Hold
0
– -$32K – 14492
2022
Q1 		– Hold
0
– – – 13080

Other funds holding TCBP

FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
NECFA
New England Capital Financial Advisors Meriden, Connecticut $365M AUM 17.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
SWM
Sanctuary Wealth Management Pocatello, Idaho $151M AUM 17.94% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citadel Advisors's TCBP Position: Q3 2024 in Review

Citadel Advisors sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q3 2024, closing a stake of 141 shares — an estimated $18.5K sold.

Citadel Advisors first reported a position in TCBP in Q2 2023 and held it in 3 quarters. The position peaked at $40K in Q2 2023. 7 funds tracked by Wall St. Rank hold TCBP as of Q3 2024.

  • Citadel Advisors reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 141 TC BioPharm (Holdings) plc American Depositary Shares shares in Q3 2024, an estimated $18.5K.
  • Citadel Advisors first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q2 2023 and held it in 3 quarters.
  • Citadel Advisors's TC BioPharm (Holdings) plc American Depositary Shares position peaked at $40K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.